Reduction in inflammatory gene expression in skeletal muscle from roux-en-Y gastric bypass patients randomized to omentectomy

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Tamboli, Robyn A ^a   Hajri, Tahar ^a   Jiang, Aixiang ^a   Marks Shulman, Pamela A ^a   Williams, D Brandon ^a   Clements, Ronald H ^a   Melvin, Willie ^a   Bowen, Benjamin P ^b   Shyr, Yu ^a   Abumrad, Naji N ^a   Flynn, Charles Robb ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN REPEAT DOMAIN 1; BINDING PROTEIN; CEREBELLAR DEGENERATION RELATED PROTEIN 1; CHEMOKINE RECEPTOR CX3CR1; CHOLESTEROL 25 HYDROXYLASE; CXCL2 CHEMOKINE; EEF1A2 BINDING PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; F BOX AND WD REPEAT DOMAIN CONTAINING 10, MRNA; HOMEOBOX C10; INTERLEUKIN 3 REGULATED NUCLEAR FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEAR FACTOR; PROTEIN; RNA; SMALL NUCLEOLAR RNA; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR, ALPHA INDUCED PROTEIN 3; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; INFLAMMATION; LAPAROSCOPIC SURGERY; MALE; MUSCLE BIOPSY; MYOSITIS; NUCLEOTIDE SEQUENCE; OMENTECTOMY; OMENTUM; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN METABOLISM; RANDOMIZED CONTROLLED TRIAL; RNA ISOLATION; ROUX Y ANASTOMOSIS; SINGLE BLIND PROCEDURE; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; STOMACH BYPASS; UNINDEXED SEQUENCE; UPREGULATION; ADOLESCENT; ANTHROPOMETRY; BLOOD; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; ANTHROPOMETRY; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; FEMALE; GASTRIC BYPASS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OMENTUM; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 83455238874     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028577     Document Type: Article

References (80)

1. Defronzo RA, (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795.
2. Abdul-Ghani MA, DeFronzo RA, (2010) Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol 2010: 476279.
3. Dandona P, Aljada A, Bandyopadhyay A, (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25: 4-7.
4. Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, et al. (2002) Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87: 2084-2089.
5. Hotamisligil GS, Shargill NS, Spiegelman BM, (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
6. Chiba Y, Saitoh S, Takagi S, Ohnishi H, Katoh N, et al. (2007) Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu study. Hypertension research: official journal of the Japanese Society of Hypertension 30: 229-236.
7. McLaughlin T, Lamendola C, Liu A, Abbasi F, (2011) Preferential Fat Deposition in Subcutaneous Versus Visceral Depots Is Associated with Insulin Sensitivity. The Journal of clinical endocrinology and metabolism.
8. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, et al. (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 117: 605-613.
9. Veilleux A, Caron-Jobin M, Noel S, Laberge PY, Tchernof A, (2011) Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes 60: 1504-1511.
10. Despres JP, (2006) Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. J Endocrinol Invest 29: 77-82.
11. Ibrahim MM, (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11: 11-18.
12. Lafontan M, Girard J, (2008) Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab 34: 317-327.
13. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, et al. (2007) Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 92: 2240-2247.
14. Fabbrini E, Tamboli RA, Magkos F, Marks-Shulman PA, Eckhauser AW, et al. (2010) Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 139: 448-455.
15. Varma V, Yao-Borengasser A, Rasouli N, Nolen GT, Phanavanh B, et al. (2009) Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 296: E1300-1310.
16. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, et al. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271: 665-668.
17. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, et al. (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nature medicine 11: 191-198.
18. Itani SI, Ruderman NB, Schmieder F, Boden G, (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51: 2005-2011.
19. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, et al. (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293: 1673-1677.
20. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, et al. (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122: 248-256 e245.
21. Pereira JA, Lazarin MA, Pareja JC, de Souza A, Muscelli E, (2003) Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery. Obes Res 11: 1495-1501.
22. Gray RE, Tanner CJ, Pories WJ, MacDonald KG, Houmard JA, (2003) Effect of weight loss on muscle lipid content in morbidly obese subjects. Am J Physiol Endocrinol Metab 284: E726-732.
23. Houmard JA, Tanner CJ, Yu C, Cunningham PG, Pories WJ, et al. (2002) Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 51: 2959-2963.
24. Friedman JE, Dohm GL, Leggett-Frazier N, Elton CW, Tapscott EB, et al. (1992) Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest 89: 701-705.
25. Pender C, Goldfine ID, Tanner CJ, Pories WJ, MacDonald KG, et al. (2004) Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia. Int J Obes Relat Metab Disord 28: 363-369.
26. Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP, (2006) GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol Genomics 27: 114-121.
27. Tataranni PA, Ravussin E, (1995) Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr 62: 730-734.
28. Pollins AC, Friedman DB, Nanney LB, (2007) Proteomic investigation of human burn wounds by 2D-difference gel electrophoresis and mass spectrometry. The Journal of surgical research 142: 143-152.
29. Brem H, Stojadinovic O, Diegelmann RF, Entero H, Lee B, et al. (2007) Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med 13: 30-39.
30. Dasu MR, Barrow RE, Herndon DN, (2005) Gene expression changes with time in skeletal muscle of severely burned children. Ann Surg 241: 647-653.
31. Greco JA 3rd, Pollins AC, Boone BE, Levy SE, Nanney LB, (2010) A microarray analysis of temporal gene expression profiles in thermally injured human skin. Burns 36: 192-204.
32. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
33. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
34. Team RDC (2010) R: A language and environment for statistical computing. R Foundation for Statistical Computing. ISBN 3-900051-07-0, URL. R website. Available: http://www.R-project.org/. Accessed 2011 Nov 15.
35. Puntschart A, Wey E, Jostarndt K, Vogt M, Wittwer M, et al. (1998) Expression of fos and jun genes in human skeletal muscle after exercise. Am J Physiol 274: C129-137.
36. Gabellini D, Colaluca IN, Vodermaier HC, Biamonti G, Giacca M, et al. (2003) Early mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progression. EMBO J 22: 3715-3724.
37. Pearen MA, Myers SA, Raichur S, Ryall JG, Lynch GS, et al. (2008) The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology 149: 2853-2865.
38. Pearen MA, Ryall JG, Maxwell MA, Ohkura N, Lynch GS, et al. (2006) The orphan nuclear receptor, NOR-1, is a target of beta-adrenergic signaling in skeletal muscle. Endocrinology 147: 5217-5227.
39. Berriz GF, Beaver JE, Cenik C, Tasan M, Roth FP, (2009) Next generation software for functional trend analysis. Bioinformatics 25: 3043-3044.
40. Kewalramani G, Bilan PJ, Klip A, (2010) Muscle insulin resistance: assault by lipids, cytokines and local macrophages. Curr Opin Clin Nutr Metab Care 13: 382-390.
41. Olefsky JM, Glass CK, (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72: 219-246.
42. Adami GF, Parodi RC, Papadia F, Marinari G, Camerini G, et al. (2005) Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion. Obesity surgery 15: 1233-1237.
43. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, et al. (2002) Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51: 144-151.
44. Johansson L, Roos M, Kullberg J, Weis J, Ahlstrom H, et al. (2008) Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy. Obesity surgery 18: 1297-1304.
45. Leichman JG, Wilson EB, Scarborough T, Aguilar D, Miller CC, 3rd, et al. (2008) Dramatic reversal of derangements in muscle metabolism and left ventricular function after bariatric surgery. The American journal of medicine 121: 966-973.
46. Klein S, (2004) The case of visceral fat: argument for the defense. The Journal of clinical investigation 113: 1530-1532.
47. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD, (2004) Splanchnic lipolysis in human obesity. The Journal of clinical investigation 113: 1582-1588.
48. Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, et al. (2005) Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 54: 3148-3153.
49. Cameron-Smith D, Burke LM, Angus DJ, Tunstall RJ, Cox GR, et al. (2003) A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle. The American journal of clinical nutrition 77: 313-318.
50. Hegarty BD, Cooney GJ, Kraegen EW, Furler SM, (2002) Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51: 1477-1484.
51. Heron-Milhavet L, Haluzik M, Yakar S, Gavrilova O, Pack S, et al. (2004) Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice. Endocrinology 145: 4667-4676.
52. Donohoe CL, Doyle SL, Reynolds JV, (2011) Visceral adiposity, insulin resistance and cancer risk. Diabetology & metabolic syndrome 3: 12.
53. Colberg SR, Simoneau JA, Thaete FL, Kelley DE, (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity. The Journal of clinical investigation 95: 1846-1853.
54. Macor C, Ruggeri A, Mazzonetto P, Federspil G, Cobelli C, et al. (1997) Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity. Metabolism: clinical and experimental 46: 123-129.
55. Coker RH, Williams RH, Yeo SE, Kortebein PM, Bodenner DL, et al. (2009) Visceral fat and adiponectin: associations with insulin resistance are tissue-specific in women. Metabolic syndrome and related disorders 7: 61-67.
56. Park K, Scott AL, (2010) Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. Journal of leukocyte biology 88: 1081-1087.
57. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, et al. (1989) Identification and characterization of macrophage inflammatory protein 2. Proceedings of the National Academy of Sciences of the United States of America 86: 612-616.
58. Yoshimura A, Naka T, Kubo M, (2007) SOCS proteins, cytokine signalling and immune regulation. Nature reviews Immunology 7: 454-465.
59. Grube BJ, Cochane CG, Ye RD, Green CE, McPhail ME, et al. (1994) Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. The Journal of biological chemistry 269: 8477-8482.
60. Hubal MJ, Rubinstein SR, Clarkson PM, (2007) Mechanisms of variability in strength loss after muscle-lengthening actions. Medicine and science in sports and exercise 39: 461-468.
61. Badi I, Cinquetti R, Frascoli M, Parolini C, Chiesa G, et al. (2009) Intracellular ANKRD1 protein levels are regulated by 26S proteasome-mediated degradation. FEBS letters 583: 2486-2492.
62. Oropeza M, Petersen B, Carnwath JW, Lucas-Hahn A, Lemme E, et al. (2009) Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation 16: 522-534.
63. Franckhauser S, Elias I, Rotter Sopasakis V, Ferre T, Nagaev I, et al. (2008) Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia 51: 1306-1316.
64. Holmes AG, Mesa JL, Neill BA, Chung J, Carey AL, et al. (2008) Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARalpha and UCP2 expression in rats. The Journal of endocrinology 198: 367-374.
65. Wolsk E, Mygind H, Grondahl TS, Pedersen BK, van Hall G, (2010) IL-6 selectively stimulates fat metabolism in human skeletal muscle. American journal of physiology Endocrinology and metabolism 299: E832-840.
66. Teran-Garcia M, Rankinen T, Koza RA, Rao DC, Bouchard C, (2005) Endurance training-induced changes in insulin sensitivity and gene expression. American journal of physiology Endocrinology and metabolism 288: E1168-1178.
67. Rowe GC, Choi CS, Neff L, Horne WC, Shulman GI, et al. (2009) Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice. Endocrinology 150: 135-143.
68. Irrcher I, Hood DA, (2004) Regulation of Egr-1, SRF, and Sp1 mRNA expression in contracting skeletal muscle cells. Journal of applied physiology 97: 2207-2213.
69. Freyssenet D, Irrcher I, Connor MK, Di Carlo M, Hood DA, (2004) Calcium-regulated changes in mitochondrial phenotype in skeletal muscle cells. American journal of physiology Cell physiology 286: C1053-1061.
70. Seale P, Ishibashi J, Scime A, Rudnicki MA, (2004) Pax7 is necessary and sufficient for the myogenic specification of CD45+:Sca1+ stem cells from injured muscle. PLoS biology 2: E130.
71. Richardson DK, Kashyap S, Bajaj M, Cusi K, Mandarino SJ, et al. (2005) Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. The Journal of biological chemistry 280: 10290-10297.
72. Kang L, Ayala JE, Lee-Young RS, Zhang Z, James FD, et al. (2011) Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin alpha2beta1 in mice. Diabetes 60: 416-426.
73. Murray LM, Thomson D, Conklin A, Wishart TM, Gillingwater TH, (2008) Loss of translation elongation factor (eEF1A2) expression in vivo differentiates between Wallerian degeneration and dying-back neuronal pathology. Journal of anatomy 213: 633-645.
74. Bosutti A, Scaggiante B, Grassi G, Guarnieri G, Biolo G, (2007) Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patients. Metabolism: clinical and experimental 56: 1629-1634.
75. Miura P, Coriati A, Belanger G, De Repentigny Y, Lee J, et al. (2010) The utrophin A 5′-UTR drives cap-independent translation exclusively in skeletal muscles of transgenic mice and interacts with eEF1A2. Human molecular genetics 19: 1211-1220.
76. Galardi S, Fatica A, Bachi A, Scaloni A, Presutti C, et al. (2002) Purified box C/D snoRNPs are able to reproduce site-specific 2′-O-methylation of target RNA in vitro. Molecular and cellular biology 22: 6663-6668.
77. Kishore S, Khanna A, Zhang Z, Hui J, Balwierz PJ, et al. The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Hum Mol Genet 19: 1153-1164.
78. Cavaille J, Buiting K, Kiefmann M, Lalande M, Brannan CI, et al. (2000) Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proceedings of the National Academy of Sciences of the United States of America 97: 14311-14316.
79. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, et al. (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American journal of physiology Endocrinology and metabolism 290: E1253-1261.
80. Bullard JH, Purdom E, Hansen KD, Dudoit S, (2010) Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC bioinformatics 11: 94.